BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18648338)

  • 1. A novel assay for screening patients for latent tuberculosis infection prior to anti-TNF therapy.
    Winthrop KL; Daley CL
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):456-7. PubMed ID: 18648338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay.
    Dinser R; Fousse M; Sester U; Albrecht K; Singh M; Köhler H; Müller-Ladner U; Sester M
    Rheumatology (Oxford); 2008 Feb; 47(2):212-8. PubMed ID: 18208824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy.
    Sester U; Junker H; Hodapp T; Schütz A; Thiele B; Meyerhans A; Köhler H; Sester M
    Nephrol Dial Transplant; 2006 Nov; 21(11):3258-68. PubMed ID: 16935889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for the diagnosis and treatment of latent tuberculosis infection and active tuberculosis in patients with inflammatory joint diseases proposed for treatment with tumour necrosis factor alpha antagonist drugs].
    Fonseca JE; Lucas H; Canhão H; Duarte R; Santos MJ; Villar M; Faustino A; Raymundo E; ;
    Rev Port Pneumol; 2006; 12(5):603-13. PubMed ID: 17117328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease.
    Schoepfer AM; Flogerzi B; Fallegger S; Schaffer T; Mueller S; Nicod L; Seibold F
    Am J Gastroenterol; 2008 Nov; 103(11):2799-806. PubMed ID: 18684188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations for the diagnosis and treatment of latent and active tuberculosis in patients with inflammatory joint diseases treated with tumour necrosis factor alpha inhibitors].
    Fonseca JE; Lucas H; Canhão H; Duarte R; Santos MJ; Villar M; Faustino A; Raymundo E; ;
    Acta Reumatol Port; 2006; 31(3):237-45. PubMed ID: 17094335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
    Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
    J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
    Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro gamma interferon tests for the detection of tuberculosis infection.
    Litwin CM
    J Immunotoxicol; 2007 Jul; 4(3):219-24. PubMed ID: 18958731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease.
    Theis VS; Rhodes JM
    Aliment Pharmacol Ther; 2008 Jan; 27(1):19-30. PubMed ID: 17944997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].
    Diel R; Hauer B; Loddenkemper R; Manger B; Krüger K
    Pneumologie; 2009 Jun; 63(6):329-34. PubMed ID: 19517358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of a whole blood interferon-gamma assay for the detection of latent tuberculosis infection in Bacille Calmette-Guérin vaccinated children.
    Chun JK; Kim CK; Kim HS; Jung GY; Lee TJ; Kim KH; Kim DS
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):389-94. PubMed ID: 18990532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors: March 2008 update.
    Fonseca JE; Lucas H; Canhão H; Duarte R; Santos MJ; Villar M; Faustino A; Raymundo E
    Acta Reumatol Port; 2008; 33(1):77-85. PubMed ID: 18344925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests.
    Demkow U; Broniarek-Samson B; Filewska M; Lewandowska K; Maciejewski J; Zycinska K; Zwolska Z; Kus J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():209-17. PubMed ID: 19218645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostics of latent tuberculosis (TB) in adult vaccinated patients (BCG) in Croatia before introduction of tumor necrosis factor antagonist therapy].
    Popović-Grle S; Babić-Naglić D
    Reumatizam; 2008; 55(1):31-5. PubMed ID: 19024268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.